Uptake and 24-month outcomes of dolutegravir- versus lopinavir-based second-line antiretroviral therapy for people with HIV in South Africa: a retrospective cohort study and emulated target trial
Brown JA. et al, (2025), Open Forum Infectious Diseases
Hair salons as a promising space to provide HIV and sexual and reproductive health services for young women in Lesotho: a citizen scientist mixed-methods study
Chiaborelli M. et al, (2025), BMC Public Health, 25
The peripartum viral load cascade and outcomes of infants exposed to HIV in Lesotho
Haenggi K. et al, (2025), HIV Medicine
Emergence of Acquired Dolutegravir Resistance in Treatment-experienced People With HIV in Lesotho
Tschumi N. et al, (2024), Clinical Infectious Diseases, 79, 1208 - 1222
Resistance-informed versus empirical management of viraemia in children and adolescents with HIV in Lesotho and Tanzania (GIVE MOVE trial): a multisite, open-label randomised controlled trial
Brown JA. et al, (2024), The Lancet Global Health, 12, e1312 - e1322
HIV viral suppression in children and adolescents 2 years after transition to dolutegravir: A multicentre cohort study
Devendra A. et al, (2024), AIDS, 38, 1013 - 1023
Clinical Relevance of Human Immunodeficiency Virus Low-level Viremia in the Dolutegravir era: Data From the Viral Load Cohort North-East Lesotho (VICONEL)
Kohler M. et al, (2024), Open Forum Infectious Diseases, 11
Two-Year Outcomes of Treatment-Experienced Adults After Programmatic Transitioning to Dolutegravir: Longitudinal Data From the VICONEL Human Immunodeficiency Virus Cohort in Lesotho
Tschumi N. et al, (2023), Clinical Infectious Diseases, 77, 1318 - 1321
Seroprofiling of Antibodies Against Endemic Human Coronaviruses and Severe Acute Respiratory Syndrome Coronavirus 2 in a Human Immunodeficiency Virus Cohort in Lesotho: Correlates of Antibody Response and Seropositivity
Brown JA. et al, (2023), Journal of Infectious Diseases, 228, 1042 - 1054
Treatment Outcomes after Offering Same-Day Initiation of Human Immunodeficiency Virus Treatment-How to Interpret Discrepancies between Different Studies
Labhardt ND. et al, (2023), Clinical Infectious Diseases, 77, 1176 - 1184